PMON208 METFORMIN, SPIRONOLACTONE AND ORAL CONTRACEPTIVES IN POLYCYSTIC OVARY SYNDROME: A NETWORK META-ANALYSIS

BACKGROUND: Polycystic ovary syndrome (PCOS) is a complex endocrine disease with awide-spectrum of clinical presentations. For this reason, several therapeutic interventions have been proposed. Metformin, spironolactone and oral contraceptives (OC), alone or in combination, have demonstrated benefit...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodriguez-Gutierrez, Rene, Raygoza-Cortez, Karina, Leal, Mariana García, de León Gutierrez, Humberto, Peña, Tomãs Alvarado, Flores, Melissa Sãenz, Santos, Yeudiel Suro, Rodríguez, Omar Fernando Rodríguez, Fuentes, Stephie Oyervides, Bautista, Mario Rodriguez, Fernãndez, Javier Obeso, Rodriguez, Andrea Flores, Colmenero, Fernando Díaz Gonzãlez, Gonzãlez-Gonzãlez, José Gerardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Reproductive Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625661/
http://dx.doi.org/10.1210/jendso/bvac150.1418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625661/
http://dx.doi.org/10.1210/jendso/bvac150.1418

Ejemplares similares